MONTREAL, June 13 /CNW Telbec/ - On June 18th, 2007 at Centre Mont-Royal
in Montreal, BIOQuebec will host a luncheon featuring James C. Greenwood,
President and CEO of Biotechnology Industry Organization (BIO), the largest
American biotech association representing over 1,000 members.
"We are particularly please with Mr. Greenwood's presence. This luncheon
will give us a better understanding of the strategic American stakes that have
an impact on the Canadian biotech industry", declared Mr. Patrick Montpetit,
Chairman of the Board at BIOQuébec.
In his presentation, "The Washington Point of View: Issues Facing the
Biotechnology Industry Today", Mr. Greenwood will share with us his vision of
the future of the biotech industry, ethical questions, and the impact Canadian
biotech companies have on the international scene. Mr. Greenwood will also
cover new legislative issues regarding property intellectual, biogeneric, and
access to the American Stock Exchange. His arrival in Montreal coincides with
the 2007 edition of BIO VentureForum East, organized by BIO and held, on this
rare occasion, outside the US.
About Mr. James C. Greenwood
Since 2005, James C. Greenwood has been President and CEO of BIO.
Previously, he represented Pennsylvania's Eighth District in the United States
House of Representatives, as well as another twelve years in the Pennsylvania
Senate and legislature. He began his career as a social worker. In his
political career, Mr. Greenwood was involved in issues regarding health care,
environment and the welfare of children.
BIOQuebec is a biotech and life sciences association representing over
230 companies and research centres in Québec. It pursues its efforts with
government authorities to advocate the wealth creation potential and growing
importance that our industry represents for Québec's economy. BIOQuebec
continues to develop a closer relationship with public decision-makers in
order to draw attention to the indispensable nature of the biotech industry,
the contribution that our member companies make to the health care system, as
well as the role that biotech plus in the whole area of economic development.
In addition, BIOQuébec has pursued its mission to act as a catalyst to prompt
biotechnology and life sciences companies to raise their profile abroad.
For further information:
For further information: Marie-France Martel, Communications and Events,
(514) 733-8411, ext. 204, email@example.com; Source: BIOQuebec,